TY - JOUR T1 - Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - 1999 LP - 2002 DO - 10.1136/ard.2011.154179 VL - 70 IS - 11 AU - Boulos Haraoui AU - Josef S Smolen AU - Daniel Aletaha AU - Ferdinand C Breedveld AU - Gerd Burmester AU - Catalin Codreanu AU - José Pereira Da Silva AU - Maarten de Wit AU - Maxime Dougados AU - Patrick Durez AU - Paul Emery AU - João Eurico Fonseca AU - Allan Gibofsky AU - Juan Gomez-Reino AU - Winfried Graninger AU - Vedat Hamuryudan AU - Maria José Jannaut Peῆa AU - Joachim Kalden AU - Tore K Kvien AU - Ieda Laurindo AU - Emilio Martin-Mola AU - Carlomaurizio Montecucco AU - Pedro Santos Moreno AU - Karel Pavelka AU - Gyula Poor AU - Mario H Cardiel AU - Ewa Stanislawska-Biernat AU - Tsutomu Takeuchi AU - Désirée van der Heijde Y1 - 2011/11/01 UR - http://ard.bmj.com/content/70/11/1999.abstract N2 - Aim To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. Methods A 10-point Likert scale (1=fully disagree, 10=fully agree) measured the level of agreement with each of 10 recommendations. A 4-point Likert scale (never, not very often, very often, always) assessed the degree to which each recommendation was being applied in current daily practice. If respondents answered ‘never’ or ‘not very often’, they were asked whether they would change their practice according to the particular recommendation. Results A total of 1901 physicians representing 34 countries participated. Both agreement with and application of recommendations was high. With regard to application of recommendations in daily practice, the majority of responses were ‘always’ and ‘very often’. A significant percentage of participants who were currently not applying these recommendations in clinical practice were willing to change their practice according to the recommendations. Conclusion The results of this survey demonstrated great support of ‘Treating RA to Target’ recommendations among the international rheumatology community. Additional efforts may be needed to encourage application of the recommendations among certain clinicians who are resistant to changing their practice. ER -